This Article Full Text Full Text (PDF) Supplemental Data Files All Versions of this Article: 19/3/781    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rico-Bautista, E. Articles by Flores-Morales, A. Search for Related Content PubMed PubMed Citation Articles by Rico-Bautista, E. Articles by Flores-Morales, A.

Suppressor of Cytokine Signaling-2 Deficiency Induces Molecular and Metabolic Changes that Partially Overlap with Growth Hormone-Dependent Effects

Department of Molecular Medicine, Karolinska Institute (E.R.-B., P.T.-E., G.N., A.F.-M.), Stockholm 17176, Sweden; and Walter and Eliza Hall Institute of Medical Research and the Cooperative Research Center for Cellular Growth Factors (C.J.G., D.J.H., W.S.A.), Melbourne, 3050 Victoria Australia

Address all correspondence and requests for reprints to: Dr. Amilcar Flores-Morales, CMM, L8:01, Karolinska Hospital, 17176 Stockholm, Sweden. E-mail: amilcar.flores{at}cmm.ki.se.

Suppressor of cytokine signaling-2 (SOCS2)-deficient (SOCS2^–/–) mice grow significantly larger than their littermates, suggesting that SOCS2 is important in the negative regulation of the actions of GH and/or IGF-I. The aim of this study was to identify genes and metabolic parameters that might contribute to the SOCS2^–/– phenotype. We demonstrate that although SOCS2 deficiency induces significant changes in hepatic gene expression, only a fraction of these overlap with known GH-induced effects in the liver, suggesting that SOCS2 might be an important regulator of other growth factors and cytokines acting on the liver. However, an important role of GH and IGF-I in the phenotype of these animals was demonstrated by an overexpression of IGF-binding protein-3 mRNA in the liver and increased levels of circulating IGF-binding protein-3. Other GH-like effects included diminished serum triglycerides and down-regulation of lipoprotein lipase in adipose tissue. Interestingly, SOCS2^–/– mice did not differ from their wild-type littermates in glucose or insulin tolerance tests, which is in contrast with the known diabetogenic effects of GH. Furthermore, there was no evidence of impaired insulin signaling in primary hepatocytes isolated from SOCS2^–/– mice. Moreover, increased expression of peroxisome proliferator-activated receptor- coactivator-1 mRNA was detected in skeletal muscle, which might contribute to normal glycemic control despite the apparent overactivity of the GH/IGF-I axis. Our data indicate that SOCS2 deficiency partially mimics a state of increased GH activity, but also results in changes that cannot be related to known GH effects.

This article has been cited by other articles:

				A. Flores-Morales, C. J. Greenhalgh, G. Norstedt, and E. Rico-Bautista Negative Regulation of Growth Hormone Receptor Signaling Mol. Endocrinol., February 1, 2006; 20(2): 241 - 253. [Abstract] [Full Text] [PDF]